The association between PD-1 gene polymorphisms and susceptibility to multiple sclerosis

References

• McElroy JP, Oksenberg JR. Multiple sclerosis genetics 2010. Neurol Clin. 2011;29(2):219–231.
   PubMed Web of Science ®Google Scholar
• Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol. 2005;23:683–747.
   PubMed Web of Science ®Google Scholar
• Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 2002;23(9):445–449.
   PubMed Web of Science ®Google Scholar
• Francisco LM, Sage PT, Sharpe AH. The PD‐1 pathway in tolerance and autoimmunity. Immunol Rev. 2010;236(1):219–242.
   PubMed Web of Science ®Google Scholar
• Markovic-Plese S, Cortese I, Wandinger K-P, et al. CD4+ CD28–costimulation-independent T cells in multiple sclerosis. J Clin Invest. 2001;108(8):1185–1194.
   PubMed Web of Science ®Google Scholar
• Anderson DE, Bieganowska KD, Bar-Or A, et al. Paradoxical inhibition of T-cell function in response to CTLA-4 blockade; heterogeneity within the human T-cell population. Nat Med. 2000;6(2):211–214.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Bertoletti A, Tanoto T. PD‐1/PD‐L1 pathway and T‐cell exhaustion in chronic hepatitis virus infection. J Viral Hepat. 2010;17(7):453–458.
   PubMed Web of Science ®Google Scholar
• Freeman GJ, Long AJ, Iwai Y, et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med. 2000;192(7):1027–1034.
   PubMed Web of Science ®Google Scholar
• Nishimura H, Nose M, Hiai H, et al. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity. 1999;11(2):141–151.
   PubMed Web of Science ®Google Scholar
• Zamani MR, Aslani S, Salmaninejad A, et al. PD-1/PD-L and autoimmunity: a growing relationship. Cell Immunol. 2016;310:27–41.
   PubMed Web of Science ®Google Scholar
• Lv F, Gao Y-F, Zhang Z-H, et al. Polymorphisms in programmed death-1 gene are not associated with chronic HBV infection in Chinese patients. World J Hepatol. 2011;3(3):72–78.
   PubMedGoogle Scholar
• Salmaninejad A, Valilou SF, Shabgah AG, et al. PD‐1/PD‐L1 pathway: basic biology and role in cancer immunotherapy. J Cell Physiol. 2019;234(10):16824–16837.
   PubMed Web of Science ®Google Scholar
• Zamani MR, Asbagh FA, Massoud AH, et al. Association between a PD-1 gene polymorphism and antisperm antibody-related infertility in Iranian men. J Assist Reprod Genet. 2015;32(1):103–106.
   PubMed Web of Science ®Google Scholar
• Mahmoudi M, Rezaiemanesh A, Harsini S, et al. PDCD1 single nucleotide polymorphisms in Iranian patients with juvenile idiopathic arthritis. Acta Med Iran. 2017;55:676–682.
   PubMedGoogle Scholar
• Shadmehri AA, Nicknam MH, Shokrgozar MA, et al. Assessment of PD-1 gene variation in patients with multiple sclerosis. Tehran Univ Med J. 2010;68(2):87–93.
   Google Scholar
• Iwamoto T, Ikari K, Inoue E, et al. Failure to confirm association between PDCD1 polymorphisms and rheumatoid arthritis in a Japanese population. J Hum Genet. 2007;52(6):557–560.
   PubMed Web of Science ®Google Scholar
• Mahmoudi M, Rezaiemanesh A, Salmaninejad A, et al. PDCD1 single nucleotide genes polymorphisms confer susceptibility to juvenile-onset systemic lupus erythematosus. Autoimmunity. 2015;48(7):488–493.
   PubMed Web of Science ®Google Scholar
• Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–173.
   PubMed Web of Science ®Google Scholar
• Marrie RA. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol. 2004;3(12):709–718.
   PubMed Web of Science ®Google Scholar
• Braun-Prado K, Petzl-Erler ML. Programmed cell death 1 gene (PDCD1) polymorphism and Pemphigus foliaceus (fogo selvagem) disease susceptibility. Genet Mol Biol. 2007;30(2):314–321.
   Web of Science ®Google Scholar
• Lin SC, Yen JH, Tsai JJ, et al. Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus. Arthritis Rheum. 2004;50(3):770–775.
   PubMedGoogle Scholar
• Prokunina L, Castillejo-López C, Öberg F, et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet. 2002;32(4):666–669.
   PubMed Web of Science ®Google Scholar
• Pawlak-Adamska E, Nowak O, Karabon L, et al. PD-1 gene polymorphic variation is linked with first symptom of disease and severity of relapsing-remitting form of MS. J Neuroimmunol. 2017;305:115–127.
   PubMed Web of Science ®Google Scholar
• Kroner A, Mehling M, Hemmer B, et al. A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol. 2005;58(1):50–57.
   PubMed Web of Science ®Google Scholar
• Ferreiros‐Vidal I, Gomez‐Reino JJ, Barros F, et al. Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population‐specific effects. Arthritis Rheum. 2004;50(8):2590–2597.
   PubMedGoogle Scholar
• Fathi F, Sadeghi E, Lotfi N, et al. Effects of the programmed cell death 1 (PDCD1) polymorphisms in susceptibility to systemic lupus erythematosus. Int J Immunogenet. 2020;47(1):57–64.
   PubMed Web of Science ®Google Scholar
• Shadmehri AA, Nicknam MH, Shokrgozar MA, et al. Assessment of PD-1 gene variation in patients with multiple sclerosis. Tehran Univ Med J. 2010;68(2):87–93.
   Google Scholar
• Haghshenas MR, Naeimi S, Talei A, et al. Program death 1 (PD1) haplotyping in patients with breast carcinoma. Mol Biol Rep. 2011;38(6):4205–4210.
   PubMed Web of Science ®Google Scholar
• Mojtahedi Z, Mohmedi M, Rahimifar S, et al. Programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with colon cancer. Gene. 2012;508(2):229–232.
   PubMed Web of Science ®Google Scholar
• Cooper JD, Smyth DJ, Bailey R, et al. The candidate genes TAF5L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes. BMC Med Genet. 2007;8(1):71.
   PubMedGoogle Scholar
• Salmaninejad A, Khoramshahi V, Azani A, et al. PD-1 and cancer: molecular mechanisms and polymorphisms. Immunogenetics. 2018;70(2):73–86.
   PubMed Web of Science ®Google Scholar
• Hua Z, Li D, Xiang G, et al. PD-1 polymorphisms are associated with sporadic breast cancer in Chinese Han population of Northeast China. Breast Cancer Res Treat. 2011;129(1):195–201.
   PubMed Web of Science ®Google Scholar
• Kong EKP, Prokunina‐Olsson L, Wong WHS, et al. A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese. Arthritis Rheum. 2005;52(4):1058–1062.
   PubMedGoogle Scholar
• De Vooght KM, Van Wijk R, Van Solinge WW. Management of gene promoter mutations in molecular diagnostics. Clin Chem. 2009;55(4):698–708.
   PubMed Web of Science ®Google Scholar
• Tahoori MT, Pourfathollah AA, Akhlaghi M, et al. Association of programmed cell death-1 (PDCD-1) gene polymorphisms with rheumatoid arthritis in Iranian patients. Clin Exp Rheumatol. 2011;29(5):763.
   PubMed Web of Science ®Google Scholar